NCT01179893View on ClinicalTrials.gov

Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis

PHASE4CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Myasthenia Gravid
Interventions
BIOLOGICAL

IVIG

Intravenous immunoglobulin

PROCEDURE

PLEX

Plasma exchange: removal of pathogenic antibodies and constituents and replacement with albumin.

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

Sponsors

Collaborators (1)

Grifols Therapeutics LLC
All Listed Sponsors
collaborator

Grifols Therapeutics LLC

INDUSTRY

lead

University Health Network, Toronto

OTHER